New research from the Center for Drug Discovery at Northeastern presents a series of molecules that can be controllably deactivated, thereby reducing the side effects of potentially valuable drugs.
At the sixth event in Northeastern’s Women Who Inspire series, CEOs of three of the area’s top pharmaceutical companies discussed the challenges and rewards of being a leader in the drug discovery industry.
Fifth-year chemistry major Mark Naniong’s research while on co-op at the Dana-Farber Cancer Institute made it to the pages of a prestigious academic journal—and inspired him to pursue a career linked to innovation in science.
New research from physics professor Mark Williams stands to transform HIV/AIDS drug discovery by elucidating a long-held paradox about the molecules that form our first line of immune defense against the virus.
At a symposium hosted by Northeastern on Tuesday, a pioneering chemist marveled at the human body’s ability to flourish in the face of exposure to thousands of harmful pathogens.
Director of Northeastern’s Antimicrobial Discovery Center elected to the American Academy of Microbiology on the strength of his research achievements